Literature DB >> 17019896

Evidence for a hallucinogen dependence syndrome developing soon after onset of hallucinogen use during adolescence.

A L Stone1, C L Storr, J C Anthony.   

Abstract

This study uses latent class methods and multiple regression to shed light on hypothesized hallucinogen dependence syndromes experienced by young people who have recently initiated hallucinogen use. It explores possible variation in risk. The study sample, identified within public-use data files of the 1999 National Household Survey on Drug Abuse (NHSDA), consists of 1186 recent-onset hallucinogen users, defined as having initiated hallucinogen use within 24 months of assessment (median elapsed time since onset of use -12 to 13 months). The recent-onset users in this sample were age 12 to 21 at the time of assessment and were between the ages of 10 and 21 at the time of their first hallucinogen use. The NHSDA included items to assess seven clinical features often associated with hallucinogen dependence, which were used in latent class modelling. Latent class analysis, in conjunction with prior theory, supports a three-class solution, with 2% of recent-onset users in a class that resembles a hallucinogen dependence syndrome, whereas 88% expressed few or no clinical features of dependence. The remaining 10% may reflect users who are at risk for dependence or in an early stage of dependence. Results from latent class regressions indicate that susceptibility to rapid transition from first hallucinogen use to onset of this hallucinogen dependence syndrome might be influenced by hallucinogenic compounds taken (for example, estimated relative risk, RR = 2.4, 95% CI = 1.6, 7.6 for users of MDMA versus users of LSD). Excess risk of rapid transition did not appear to depend upon age, sex, or race/ethnicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17019896      PMCID: PMC6878397          DOI: 10.1002/mpr.188

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  20 in total

1.  Latent class marginal regression models for modelling youthful drug involvement and its suspected influences.

Authors:  B A Reboussin; J C Anthony
Journal:  Stat Med       Date:  2001-02-28       Impact factor: 2.373

2.  Management of hallucinogen abuse.

Authors:  L M Haddad
Journal:  Am Fam Physician       Date:  1976-07       Impact factor: 3.292

3.  Classification and short-term course of DSM-IV cannabis, hallucinogen, cocaine, and opioid disorders in treated adolescents.

Authors:  Tammy Chung; Christopher S Martin
Journal:  J Consult Clin Psychol       Date:  2005-12

4.  Early-onset drug use and risk of later drug problems.

Authors:  J C Anthony; K R Petronis
Journal:  Drug Alcohol Depend       Date:  1995-11       Impact factor: 4.492

5.  Age of onset of drug use as a factor in drug and other disorders.

Authors:  L N Robins; T R Przybeck
Journal:  NIDA Res Monogr       Date:  1985

6.  Hallucinogen, opiate, sedative and stimulant use and abuse in a population-based sample of female twins.

Authors:  K S Kendler; L Karkowski; C A Prescott
Journal:  Acta Psychiatr Scand       Date:  1999-05       Impact factor: 6.392

7.  Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000-2001.

Authors:  Chuan-Yu Chen; Megan S O'Brien; James C Anthony
Journal:  Drug Alcohol Depend       Date:  2005-02-10       Impact factor: 4.492

8.  Epidemiological estimates of risk in the process of becoming dependent upon cocaine: cocaine hydrochloride powder versus crack cocaine.

Authors:  Chuan-Yu Chen; James C Anthony
Journal:  Psychopharmacology (Berl)       Date:  2003-11-04       Impact factor: 4.530

9.  Is the use of ecstasy and hallucinogens increasing? Results from a community study.

Authors:  P Schuster; R Lieb; C Lamertz; H U Wittchen
Journal:  Eur Addict Res       Date:  1998-03       Impact factor: 3.015

Review 10.  Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review.

Authors:  H U Wittchen
Journal:  J Psychiatr Res       Date:  1994 Jan-Feb       Impact factor: 4.791

View more
  11 in total

1.  Understanding the patterns and distribution of opioid analgesic dependence symptoms using a latent empirical approach.

Authors:  L A Ghandour; S S Martins; H D Chilcoat
Journal:  Int J Methods Psychiatr Res       Date:  2008       Impact factor: 4.035

2.  Who is becoming hallucinogen dependent soon after hallucinogen use starts?

Authors:  Andrea L Stone; Megan S O'Brien; Alejandro De La Torre; James C Anthony
Journal:  Drug Alcohol Depend       Date:  2006-09-20       Impact factor: 4.492

3.  Extra-medical stimulant dependence among recent initiates.

Authors:  Megan S O'Brien; James C Anthony
Journal:  Drug Alcohol Depend       Date:  2009-06-09       Impact factor: 4.492

4.  An item response theory analysis of DSM-IV criteria for hallucinogen abuse and dependence in adolescents.

Authors:  Li-Tzy Wu; Jeng-Jong Pan; Chongming Yang; Bryce B Reeve; Dan G Blazer
Journal:  Addict Behav       Date:  2009-10-22       Impact factor: 3.913

5.  Hallucinogen-related disorders in a national sample of adolescents: the influence of ecstasy/MDMA use.

Authors:  Li-Tzy Wu; Christopher L Ringwalt; Roger D Weiss; Dan G Blazer
Journal:  Drug Alcohol Depend       Date:  2009-06-04       Impact factor: 4.492

6.  Test-re-test reliability of DSM-IV adopted criteria for 3,4-methylenedioxymethamphetamine (MDMA) abuse and dependence: a cross-national study.

Authors:  Linda B Cottler; Kit Sang Leung; Arbi Ben Abdallah
Journal:  Addiction       Date:  2009-08-04       Impact factor: 6.526

7.  Hallucinogen use disorders among adult users of MDMA and other hallucinogens.

Authors:  Li-Tzy Wu; Christopher L Ringwalt; Paolo Mannelli; Ashwin A Patkar
Journal:  Am J Addict       Date:  2008 Sep-Oct

Review 8.  The serotonin 5-HT2C receptor and the non-addictive nature of classic hallucinogens.

Authors:  Clinton E Canal; Kevin S Murnane
Journal:  J Psychopharmacol       Date:  2016-11-15       Impact factor: 4.153

9.  Importance of dopaminergic neurotransmission for the RU 24969-induced locomotor activity of male and female rats during the preweanling period.

Authors:  Sanders A McDougall; Nazaret R Montejano; Ginny I Park; Jasmine A M Robinson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-11-18       Impact factor: 3.000

Review 10.  Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.

Authors:  Anne K Schlag; Jacob Aday; Iram Salam; Jo C Neill; David J Nutt
Journal:  J Psychopharmacol       Date:  2022-02-02       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.